Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]


Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.


Can low-dose naltrexone relieve pain? (News)

Submitted by baileylynn_100964 on Sat, 01/15/2022 - 22:01

Can low-dose naltrexone relieve pain?

The Seattle times
12 Jan 2022

At low doses (1 to 4.5 mg) it is prescribed to ease the pain and inflammation associated with conditions such as fibromyalgia, chronic pain syndrome, multiple sclerosis and Crohn’s disease

Bron Webster interviews Linda Elsegood (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Shares her Multiple Sclerosis and Low Dose Naltrexone (LDN) Journey

Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis

J Neurosci Res
25 November 2021


Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)


Paul Anderson, NMD - Immune Therapies for Multiple Sclerosis (2017 Conference) (LDN, low dose naltrexone)

How LDN can be so successful in treating Multiple Sclerosis (MS) by boosting the immune system and improving the overall wellbeing of the patient.


Mark Cooper, PhD - LDN, Neuroinflammation, and Movement Disorders (2018 Conference) (LDN, low dose naltrexone)